All studies
AuthorisedTherapeutic exploratory (Phase II)Interventional

Èn dosis intravenøs penicillin som tillæg til peroral penicillin i behandlingen af akut tonsillitis, peritonsillær phlegmone og peritonsillær absces – et randomiseret, dobbeltblindet, placebo-kontrolleret studie

Tonsillitis is a painful throat infection that can sometimes cause severe swelling or a collection of pus called an abscess (quinsy). The usual treatment is a course of antibiotic tablets taken by mouth. This trial is investigating whether adding a single dose of penicillin into a vein at the start of treatment helps people recover more quickly. All participants will receive standard oral penicillin tablets to take at home. Alongside this, half the participants will receive an injection of penicillin through a drip, while the other half will receive a dummy saltwater injection (placebo). Neither patients nor doctors can choose who gets which injection. Researchers will measure pain levels, time to recovery, and the number of painkillers used over the first week. They will also follow up after 6 and 12 months to see if the treatment reduces future throat infections or the need for tonsil surgery.

At a glance

Status
Authorised
Phase
Therapeutic exploratory (Phase II)
Sponsor
Region Midtjylland
Enrolment target
154
Start
21 Aug 2026

What is this study about?

Severe sore throats and tonsillitis are very common reasons to see a doctor or visit hospital. In some cases, the infection can spread into deeper throat tissues or form a painful pocket of pus next to the tonsil, known as a quinsy or peritonsillar abscess. These severe infections can make it difficult and painful to swallow, talk, or even open your mouth. Standard care usually involves taking antibiotic tablets, such as penicillin, at home.

While antibiotic tablets work well for most people, recovery can sometimes feel slow. In this trial, doctors want to find out if giving a single "booster" dose of penicillin straight into a vein (intravenously) at the very beginning of treatment can help people feel better sooner. By delivering the medicine directly into the bloodstream, it may fight the infection more rapidly than tablets alone.

Researchers will closely track throat pain and general recovery over the first week to see if symptoms ease faster. They are also looking at the bigger picture over a full year. The study will monitor whether this early extra dose prevents complications, stops the infection from coming back, or reduces the likelihood of needing an operation to remove the tonsils.

Key takeaways

  • Tests whether adding one dose of intravenous penicillin speeds up recovery from severe tonsil infections.
  • All participants receive the standard course of oral penicillin tablets.
  • Half of the participants receive intravenous penicillin, and half receive an inactive saltwater injection.
  • Pain and recovery are tracked during the first week, with brief follow-ups at 6 and 12 months.
  • Open to adults aged 18 and older who do not have a penicillin allergy.

Who may be eligible?

This study is open to adults aged 18 and older who have been diagnosed with acute tonsillitis, deep throat tissue swelling (phlegmon), or a throat abscess (quinsy). Both men and women can take part.

Because the study medicine is penicillin, anyone with a known allergy to penicillin or similar antibiotics cannot join. People who have already started certain other antibiotic treatments or who have specific medical conditions may also not be suitable.

A doctor at the clinic or hospital will examine your throat, review your general health, and check your medical history to make sure taking part is completely safe for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years of age or older?
  2. Have you been diagnosed with acute tonsillitis, severe throat swelling, or a throat abscess (quinsy)?
  3. Are you able to take penicillin safely without having an allergic reaction?
  4. Are you willing to record your pain and medicine use for the first 7 days?
  5. Are you happy to be contacted for quick follow-ups at 6 and 12 months?
Answer every question to see your result.

What does participation involve?

If you take part, you will be given standard penicillin tablets to take by mouth at home. You will also receive one injection through a small plastic tube in your vein (a cannula). This injection will contain either penicillin or a harmless saltwater solution.

During the first seven days, you will be asked to track your pain, record how many painkillers you take, and note when your symptoms start to clear. You will have a brief assessment around Day 14 to check that your throat has healed and that you have had no complications.

After this, the research team will check in with you at 6 months and 12 months. These check-ins are usually quick and can often be done over the phone or online to see if your throat infection has returned or if you have needed tonsil surgery. In total, your participation lasts for 12 months.

Potential risks and benefits

Taking part may help your throat pain clear up faster if you receive the intravenous penicillin, though this cannot be guaranteed. The findings will also help doctors improve treatments for people with severe throat infections in the future. The risks are similar to standard antibiotic care, including mild side effects like an upset stomach, loose stools, or mild skin rashes. You might also experience mild bruising or tenderness where the drip is placed. Serious allergic reactions are rare and will be monitored closely by medical staff. Taking part is completely voluntary, and you are free to leave the study at any time without your regular NHS care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Denmark

Common questions

What is quinsy?

Quinsy is a complication of tonsillitis where an abscess (a pocket of pus) forms between your tonsil and the wall of your throat. It can cause severe pain and swelling.

What is a placebo?

A placebo is a harmless dummy treatment designed to look identical to the real medicine. In this trial, it is a simple saltwater injection.

Will I still receive standard antibiotics?

Yes. Every person who joins the study receives the standard course of penicillin tablets to take at home.

Can I choose to have the intravenous penicillin instead of the placebo?

No. A computer randomly decides who receives the intravenous penicillin and who receives the saltwater injection, ensuring the test is fair and unbiased.

Can I join if I am allergic to penicillin?

No. If you have an allergy to penicillin, it is not safe for you to take part, and your doctor will offer an alternative antibiotic.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.